Stevanato Group (NYSE:STVN) Sees Large Volume Increase

Stevanato Group S.p.A. (NYSE:STVN) saw unusually-strong trading volume on Friday . Approximately 532,098 shares were traded during trading, an increase of 37% from the previous session’s volume of 389,101 shares.The stock last traded at €22.06 ($23.72) and had previously closed at €21.10 ($22.69).

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on STVN shares. Morgan Stanley reiterated an “equal weight” rating and set a $30.00 target price on shares of Stevanato Group in a research report on Monday, April 22nd. BNP Paribas started coverage on Stevanato Group in a research report on Monday, April 22nd. They set an “outperform” rating on the stock. Finally, Stephens reiterated an “overweight” rating and set a $38.00 target price on shares of Stevanato Group in a research report on Monday, March 25th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of €34.29 ($36.87).

Stevanato Group Stock Performance

The business has a fifty day simple moving average of €28.91 and a two-hundred day simple moving average of €28.89. The company has a quick ratio of 1.06, a current ratio of 1.50 and a debt-to-equity ratio of 0.23.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of €0.12 ($0.13) by (€0.03) (($0.03)). The firm had revenue of €256.24 million during the quarter, compared to analysts’ expectations of €261.28 million. Stevanato Group had a net margin of 12.57% and a return on equity of 13.28%. Sell-side analysts expect that Stevanato Group S.p.A. will post 0.67 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Conestoga Capital Advisors LLC raised its holdings in shares of Stevanato Group by 48.7% during the 1st quarter. Conestoga Capital Advisors LLC now owns 6,778,893 shares of the company’s stock worth $217,602,000 after acquiring an additional 2,221,615 shares during the period. Copeland Capital Management LLC raised its holdings in shares of Stevanato Group by 18.6% during the 4th quarter. Copeland Capital Management LLC now owns 2,088,778 shares of the company’s stock worth $57,003,000 after acquiring an additional 327,960 shares during the period. TimesSquare Capital Management LLC raised its holdings in shares of Stevanato Group by 64.2% during the 3rd quarter. TimesSquare Capital Management LLC now owns 2,032,361 shares of the company’s stock worth $60,402,000 after acquiring an additional 794,391 shares during the period. Sands Capital Management LLC raised its holdings in shares of Stevanato Group by 1.6% during the 4th quarter. Sands Capital Management LLC now owns 1,884,330 shares of the company’s stock worth $51,423,000 after acquiring an additional 29,450 shares during the period. Finally, Jackson Square Partners LLC raised its holdings in shares of Stevanato Group by 763.9% during the 1st quarter. Jackson Square Partners LLC now owns 1,824,240 shares of the company’s stock worth $58,558,000 after acquiring an additional 1,613,075 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.